MEDIA
Read our latest company announcements and media coverage. Stay on top of current industry news and trends featuring our leading genetics experts as they contribute advice, information, and best practices.
FEATURED
Genetic Testing Challenges in Oncology: Karyotype, Germline Clues in Somatic Diagnosis Lost in Translation
A 61-year old Jewish woman with a hematologic malignancy and a family history of breast cancer was referred to genetic counseling. As part of her work-up, the heme-onc had ordered somatic testing of the patient’s blood cancer, which revealed a TP53 variant at a high...
In The News
Genetic Testing Challenges in Oncology: Patient with Pending Bill has BRCA1 Result Withheld
A patient diagnosed with metastatic, poorly differentiated, stage IIIB invasive ductal, triple-negative breast cancer was not given pre- or post-test genetic counseling before undergoing genetic testing. After seeing another surgeon for bilateral mastectomy, the...
Precision Oncology in 2022: New Drugs and Tests Amid Ongoing Access Barriers
In 2022, many new therapies and tests for cancer were approved, but a significant number of patients are still not receiving appropriate therapies. Suboptimal testing paradigms, reimbursement issues and physicians' inability to keep up with rapidly advancing science...
Myriad Genetics (MYGN) To Share Guarded BRCA Variant Information In Public Database
Myriad Genetics is set to share information about guarded BRCA variants in a public database, marking a significant shift in the company's approach to sharing genetic information. Previously, the company had been criticized for guarding such information and limiting...
The Latest Thinking on Genetic Testing
Ellen Matloff sits down with Everyday Health to discuss the past, present, and future of genetic testing. With advances in technology and research, genetic testing is becoming increasingly accessible and informative. However, there are still many misconceptions and...
Genetic Testing Challenges in Oncology: Missed Variant Update Delays Li-Fraumeni Diagnosis
A woman with a history of breast cancer and a family history of pancreatic cancer was diagnosed with Cushing's disease. She was referred to a genetic counselor who found that the patient had a TP53 variant associated with Li-Fraumeni syndrome (LFS) that had been...
Your Baby’s Newborn Screening Blood Sample Could Be Used To Convict You Of A Crime. It Just Happened In New Jersey.
Newborn screening is a program in the US that tests newborn babies for various conditions that could affect their long-term health or survival. This testing has been lifesaving for many babies and families. However, there are concerns that states may keep the newborn...
Press Releases
My Gene Counsel Selected by Foundation for Prader-Willi Research to Enable Responsible Return of Results for Genome Sequencing Project
The Prader-Willi syndrome Genome Project will utilize My Gene Counsel's updating, digital genetic counseling reports to help research participants better understand their genetic test results. NEW HAVEN, CONN. (PRWEB) JUNE 24, 2021 My Gene Counsel, a digital health...
My Gene Counsel Partners with O’Neal Comprehensive Cancer Center at UAB to Boost Genetic Testing and Improve Precision Cancer Care
The digital solution will enable physician-initiated testing, greater clinical support, and better use of genetic counseling resources. NEW HAVEN, CONN. (PRWEB) MARCH 30, 2021 My Gene Counsel, a digital health company that provides innovative genetic counseling...
My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe
With transformative digital technologies playing an increasingly critical role in health care delivery, the two companies have joined forces on a digital genomic solution that will increase efficiencies and outcomes within the highly specialized space of oncology. NEW...
Vanderbilt Selects My Gene Counsel to Partner on Large 5-Year NIH Grant
My Gene Counsel is pleased to announce that we have partnered with Vanderbilt University Medical Center and the University of South Florida on the highly innovative Improving Care After Inherited Cancer Testing (IMPACT) Study. This 5-year project will be supported by...
My Gene Counsel Partners with the Multiple Myeloma Research Foundation on Groundbreaking Genomic Study
The Multiple Myeloma Research Foundation (MMRF) is working to democratize healthcare for cancer patients today with the launch of CureCloud®, a first-of-its-kind, direct-to-patient research study, powered by genomic and clinical information from multiple myeloma...
My Gene Counsel Partners with UConn Health to Provide Expanded Genetic Counseling Services
Easy-to-understand genetic counseling reports will lead to more appropriate follow-up and better health outcomes. NEW HAVEN, CONN. (PRWEB) APRIL 16, 2020 More than 600 people undergo genetic counseling and testing each year as part of the Neag Comprehensive Cancer...
Multimedia
Looking Back on the 10-year Anniversary of the SCOTUS Decision
Exponential growth is occurring in clinical genomics. A patient found to have a pathogenic variant 10 years ago has likely lived through dozens of updates to risk estimates and management guidelines related to that diagnosis.
Genetic Testing Errors Negatively Impact Therapeutic Decision Making
In this episode, we continue our discussion with Meagan Farmer and Danielle Bonadies as we discuss how the Top Errors in Genetic Testing may be negatively affecting therapeutic decision making. We also discuss ways that life science companies may be able to...
Top Errors in Genetic Testing
In today's episode we take a look at some of the significant challenges and errors we are seeing in the use of genetic and genomic testing, as they become mainstreamed into our clinical treatment protocols. Today we highlight the Top Errors in Genetic Testing and how...
Genetic Testing: Leveraging Results to Identify Patients for New Therapies
In this episode of The Kinetix Group’s Healthcare Insights podcast, Danielle Bonadies, My Gene Counsel’s Director of Genetics, shares ideas about how to leverage genetic testing for clinical trial recruitment, as well as being able to quickly identify patients who might benefit from a new therapy.
Genetic Testing: Managing Updates to Medical Management and Risk Profiling
In this episode of The Kinetix Group’s Healthcare Insights podcast, Danielle Bonadies, My Gene Counsel’s Director of Genetics, shares the results of a recent study that suggests just how much patients and providers may be struggling to keep up with the latest genetic updates.
NSGC 2021 Poster Presentation Video
Exponential growth is occurring in clinical genomics. A patient found to have a pathogenic variant 10 years ago has likely lived through dozens of updates to risk estimates and management guidelines related to that diagnosis.